BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26751366)

  • 1. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
    Paino M; Aletraris L; Roman P
    J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational correlates of service availability in outpatient substance abuse treatment programs.
    Edwards JR; Knight DK; Flynn PM
    J Behav Health Serv Res; 2011 Oct; 38(4):432-43. PubMed ID: 21107915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Service delivery in substance abuse treatment: reexamining "comprehensive" care.
    Ducharme LJ; Mello HL; Roman PM; Knudsen HK; Johnson JA
    J Behav Health Serv Res; 2007 Apr; 34(2):121-36. PubMed ID: 17390225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.
    Aletraris L; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():1-8. PubMed ID: 25934459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which substance abuse treatment facilities offer dual diagnosis programs?
    Mojtabai R
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):525-36. PubMed ID: 15540491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rural substance use treatment centers in the United States: an assessment of treatment quality by location.
    Bond Edmond M; Aletraris L; Roman PM
    Am J Drug Alcohol Abuse; 2015; 41(5):449-57. PubMed ID: 26337202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adoption of wraparound services among substance abuse treatment organizations serving criminal offenders: The role of a women-specific program.
    Oser C; Knudsen H; Staton-Tindall M; Leukefeld C
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1(Suppl 1):S82-90. PubMed ID: 19181457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between U.S. substance abuse treatment facilities that do and do not offer domestic violence services.
    Cohn A; Najavits LM
    Psychiatr Serv; 2014 Apr; 65(4):504-10. PubMed ID: 24430366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Indians with substance use disorders: treatment needs and comorbid conditions.
    Rieckmann T; McCarty D; Kovas A; Spicer P; Bray J; Gilbert S; Mercer J
    Am J Drug Alcohol Abuse; 2012 Sep; 38(5):498-504. PubMed ID: 22931085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities.
    Arndt S; Acion L; White K
    Drug Alcohol Depend; 2013 Oct; 132(3):547-54. PubMed ID: 23664124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Client-service matching in substance abuse treatment for women with children.
    Smith BD; Marsh JC
    J Subst Abuse Treat; 2002 Apr; 22(3):161-8. PubMed ID: 12039620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organizational characteristics of drug abuse treatment programs for offenders.
    Grella CE; Greenwell L; Prendergast M; Farabee D; Hall E; Cartier J; Burdon W
    J Subst Abuse Treat; 2007 Apr; 32(3):291-300. PubMed ID: 17383553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of change in the provision of services within outpatient substance abuse treatment programs.
    Knight DK; Edwards JR; Flynn PM
    J Public Health Manag Pract; 2010; 16(6):553-63. PubMed ID: 20885186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of off-label medications in substance abuse treatment programs.
    Paino M; Aletraris L; Roman PM
    Subst Abus; 2020; 41(3):340-346. PubMed ID: 31361567
    [No Abstract]   [Full Text] [Related]  

  • 17. Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.
    Mauro PM; Furr-Holden CD; Strain EC; Crum RM; Mojtabai R
    Drug Alcohol Depend; 2016 Jun; 163():108-15. PubMed ID: 27106113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matching clients' needs with drug treatment services.
    Hser YI; Polinsky ML; Maglione M; Anglin MD
    J Subst Abuse Treat; 1999 Jun; 16(4):299-305. PubMed ID: 10349602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-service prevention programs for pregnant and parenting women with substance use and multiple vulnerabilities: Program structure and clients' perspectives on wraparound programming.
    Rutman D; Hubberstey C; Poole N; Schmidt RA; Van Bibber M
    BMC Pregnancy Childbirth; 2020 Aug; 20(1):441. PubMed ID: 32746789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment.
    Paino M; Aletraris L; Roman PM
    Subst Abus; 2015; 36(4):462-9. PubMed ID: 25257691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.